4th International Conference on
Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore, USA
OMICS International: http://omicsonline.org
Vaccine Conferences: http://conferenceseries.com/immunolog...
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nursing Conferences: http://nursingconference.com
Abstract:
The platforms currently employed in the treatment of retinal diseases include small molecules such as fluocinoloneacetonide (Retisert®) and dexamethasone (Ozurdex®), and large molecular entities such as aptamers (Macugen®), Fabs (Lucentis®), and Mabs (off label Avastin®). Other therapeutic approaches such as siRNAs, gene therapy, and nanomedicine, have been examined in ophthalmic clinical trials. In the context of delivery of therapeutics with sustained exposure to intraocular tissues, molecules like siRNAs or approaches such as gene delivery would appear to be optimal platforms, especially for targeting retinal neurons, which are non-mitotic cells. However, significant challenges have been encountered, and the horizon for therapeutic success seems cloudy due to the many clinical trial failures. This talk will discuss recent victories and challenges in gene silencing (siRNA’s) and gene delivery (AAV) and highlight potential strategies for future success.
Biography:
Kay Rittenhouse has an extensive career in ophthalmic drug research and development, spanning from drug discovery, translational research, clinical development through launch. She has developed drug targets presented on platforms such as small molecules, aptamers, antibodies, and siRNAs. She is a sought after presenter and chair of scientific conferences and forums and has published abstracts, book chapters, and manuscripts for peer reviewed journals. Her drug development expertise includes indications such as glaucoma, retinal diseases such as diabetic retinopathy and AMD, uveitis, and diseases of the ocular surface. She received a Ph.D. in pharmacokinetics from the University of North Carolina at Chapel Hill. Her dissertation research explored the pharmacodynamics of glaucoma drugs and special expertise in ocular microdialysis. She has pharmaceutical industry experience, having worked at Alcon Laboratories, Bausch and Lomb, and Pfizer).
camera iphone 8 plus apk Kay D. Rittenhouse|Ocular Drug Development Strategies LLC| Ophthamology 2014 | OMICS International | |
1 Likes | 1 Dislikes |
162 views views | 79 followers |
People & Blogs | Upload TimePublished on 25 Aug 2015 |
Related keywords
camera iphone x,camera iphone x vs xr,video phone beyonce mp3,video phone commax,video phone screen,camera phone ranking,video phone letra,video phone wikipedia,sharing outlook calendar,video phone number,sharing network 5k,camera phone x - os 12 camera apk,video phone gaga,video phone beyonce lyrics,sharing amazon prime,sharingan eyes,sharing shelf,video phone é a continuação de telephone,sharing community,camera iphone 7 plus,camera iphone x apk,video phone beyonce letra,camera iphone apk,sharing is caring,camera phone x apk,sharing network,sharingan contacts,camera iphone 8,video phone lyrics,camera iphone 7 vs iphone 8,camera iphone 7,camera iphone 6,video phone ft lady gaga,video phone beyonce,camera phone x,sharingan naruto,video phone tradução,video phone extended remix,camera phone 2019,video phone call,sharingbox,sharing google calendar,video phone lady gaga,camera iphone xr vs xs,video phone feat lady gaga,camera iphone,camera phone comparison,sharing economy,sharingan,sharing is caring meme,sharing wifi password,sharingan tattoo,sharing kindle books,sharing community yonkers,video phone beyonce lady gaga,app video iphone,sharing wifi iphone,camera iphone 8 plus,camera iphone xr,
Không có nhận xét nào:
Đăng nhận xét